Anti-Cancer Drugs carries 4,713 indexed papers, 102,950 citations, h-index 114 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Anti-Cancer Drugs sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at http://journals.lww.com/anti-cancerdrugs/pages/default.aspx.

Use the feed below to follow new Anti-Cancer Drugs publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.